ORX:STO
Orexo AB
5,35 SEK
arrow_downward
-1,29%(-0,070) 1D
21-окт., 17:29:38 GMT+2 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
5,52 SEK
High
5,65 SEK
Low
5,35 SEK
Mkt. cap
187,93 млн
Avg. vol.
115,34 миң
Volume
57,41 миң
P/E ratio
0,23
52-wk high
40,10 SEK
52-wk low
5,35 SEK
EPS
23,61 SEK
Shares outstanding
35,13 млн
No. of employees
61
Open
5,52 SEK
High
5,65 SEK
Low
5,35 SEK
Mkt. cap
187,93 млн
Avg. vol.
115,34 миң
Volume
57,41 миң
P/E ratio
0,23
52-wk high
40,10 SEK
52-wk low
5,35 SEK
EPS
23,61 SEK
Shares outstanding
35,13 млн
No. of employees
61
News stories
From web sources and news partners
Stock Titan
·
31 мүнөт мурун
Farm and forest waste could become jet fuel. XCF Global is adding the technology.
Yahoo Finance
·
49 мүнөт мурун
No surprises in Lam Research’s (NASDAQ:LRCX) Q3 sales numbers but stock drops
FinancialContent
·
27 мүнөт мурун
Cathay General Bancorp (NASDAQ:CATY) posts better-than-expected sales in Q3 2026
Investor's Business Daily
·
6 мүнөт мурун
Nasdaq Pops 1.1%, Fueled By SpaceX Earnings: Salesforce, ADI, Qualys In Focus
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB